Prof. Dr. Xinmei Zhang, Women’s Hospital, School of Medicine, Zhejiang University, China
Prof. Xinmei Zhang is the Chief Physician at the Women’s Hospital, School of Medicine, Zhejiang University, and a professor in the same institution. With over two decades of clinical and academic experience in gynecology, she has become a leading expert in the diagnosis and treatment of gynecological diseases, particularly endometriosis and adenomyosis. Her work integrates clinical excellence with cutting-edge research, focusing on women’s reproductive health, minimally invasive surgery, and gynecologic oncology. Prof. Zhang also holds several editorial roles in international journals and actively collaborates with institutions worldwide including MD Anderson Cancer Center (USA), Cochin Hospital (France), and Fudan University (Brazil). As an ambassador and key committee leader in multiple gynecological associations, she contributes significantly to shaping global standards in reproductive health. Her numerous publications and international recognition underscore her commitment to advancing women’s health through translational research and global collaboration.
Publication Profile:
Orcid
Scopus
Strengths for the Award:
-
Consistent Academic Excellence
-
Over 20 years of service in clinical and academic gynecology.
-
Held dual leadership roles: Chief Physician and Professor at Zhejiang University.
-
Ph.D. in medicine and visiting scholarship in Australia show strong academic foundation and international exposure.
-
Extensive Research Contributions
-
A strong record of peer-reviewed publications (2025–2019), many in indexed international journals.
-
Research impact areas: endometriosis, adenomyosis, gynecologic oncology, drug delivery, and minimally invasive surgery.
-
Editorial and Leadership Roles
-
Editorial board member of top journals including Annals of Translational Medicine and Chinese Journal of Obstetrics and Gynecology.
-
Vice/Chairman positions in national and international medical societies, including the World Endometriosis Association.
-
International Collaborations
-
Collaborates with leading institutions in USA (MD Anderson), France (Cochin Hospital), Brazil, and Russia, enhancing research diversity and relevance.
-
Innovative Methods
Areas for Improvement:
-
Interdisciplinary Expansion
-
While strong in clinical research, greater integration with AI, bioinformatics, or digital diagnostics could elevate research scope.
-
Public Health Impact
-
Global Recognition
-
While collaborations exist, active presence in global conferences, panels, or international guideline development would boost global profile.
Education:
Prof. Xinmei Zhang received her Ph.D. in Medicine from Zhejiang University between August 2009 and December 2011. She pursued advanced clinical training and research with a focus on gynecology and reproductive health. Earlier in her career, she served as a visiting scholar at Queensland University Adult Hospital, Australia, in 2003, where she gained international exposure in clinical research and practice. This experience enriched her global perspective and deepened her understanding of women’s health issues. Her rigorous academic background laid the foundation for a strong career in translational gynecology, merging laboratory discoveries with clinical application. Prof. Zhang’s education has equipped her with both theoretical knowledge and practical skills in molecular medicine, surgical gynecology, and women’s reproductive disorders. As an educator and researcher, she continues to mentor young clinicians and researchers in China and abroad, ensuring the next generation inherits both technical expertise and a strong ethical foundation.
Experience:
Prof. Xinmei Zhang has been serving as a Chief Physician at the Women’s Hospital, Zhejiang University since 2005, and was promoted to Professor at the School of Medicine in 2021. Her work encompasses clinical leadership, research coordination, and educational mentorship. As the head of the Department of Gynecology and co-lead at the Zhejiang Provincial Key Laboratory for Precision Diagnosis and Therapy of Major Gynecological Diseases, she spearheads initiatives in translational medicine. Her editorial appointments include prominent journals such as the Chinese Journal of Obstetrics and Gynecology and Annals of Translational Medicine. She is also a recognized leader in several professional organizations, including serving as Vice Chairman in multiple national and regional medical associations. Prof. Zhang has conducted multi-center clinical studies, developed advanced surgical techniques, and collaborated internationally on research projects. Her rich experience makes her a cornerstone in China’s gynecological research and healthcare innovation.
Research Focus:
Prof. Xinmei Zhang’s research centers on endometriosis, adenomyosis, and gynecologic oncology, with a strong emphasis on the molecular mechanisms, immune pathways, and targeted therapies. She investigates inflammatory chemokines (e.g., CCL2, CCR4, CCL18), epithelial-mesenchymal transition, neuroangiogenesis, and tumorigenic signaling pathways, bridging lab-based molecular research with clinical treatment strategies. Her studies explore novel biomarkers for diagnosis (e.g., ROMA Index for endometrial cancer) and innovative therapeutic models like curcumin–paclitaxel nano-delivery systems. Prof. Zhang has also pioneered methods for isolating ectopic stromal and epithelial cells to model adenomyosis, thus facilitating personalized medicine approaches. Her cross-border collaborations strengthen her work’s global relevance, especially in addressing complex conditions that impact women’s reproductive health and quality of life. With a publication record in high-impact journals, she contributes both to fundamental science and its translation into patient care. Her research is backed by strong institutional support and an extensive global academic network.
Publication Top Notes:
CCL2/CCR4 participates in mast cell-mediated epithelial mesenchymal transition in endometriosis – Reproductive BioMedicine Online (2025)
CCL18 promotes endometriosis by increasing endometrial cell migration and neuroangiogenesis – European Journal of Histochemistry (2024)
A method for isolating and culturing ectopic epithelial and stromal cells to study human adenomyosis – Archives of Gynecology and Obstetrics (2023)
A method for isolating and culturing ectopic epithelial and stromal cells to study human adenomyosis – Preprint Version (2023)
ROMA Index Is an Effective Predictor for Advanced Endometrial Cancer before Surgery – Disease Markers (2022)
Anemia-Associated Platelets and Plasma Prothrombin Time Increase in Patients with Adenomyosis – Journal of Clinical Medicine (2022)
Long-Term Pregnancy Outcomes of Patients with Diffuse Adenomyosis after Double-Flap Adenomyomectomy – Journal of Clinical Medicine (2022)
RON Mediates Tumor‐Promoting Effects in Endometrial Adenocarcinoma – BioMed Research International (2021)
Co-Delivery of Curcumin and Paclitaxel by “Core-Shell” Targeting Amphiphilic Copolymer to Reverse Resistance in the Treatment of Ovarian Cancer – International Journal of Nanomedicine (2019)
Comparisons of the efficacy and recurrence of adenomyomectomy for severe uterine diffuse adenomyosis via laparotomy versus laparoscopy – Journal of Pain Research (2019)
Conclusion:
Prof. Xinmei Zhang is a highly qualified candidate for the Best Researcher Award. Her sustained contributions to women’s health, innovative clinical and molecular research, strong global collaborations, and leadership in academic medicine represent the ideal profile of a world-class researcher. Her work not only advances science but translates directly into improved patient care—an essential criterion for this award.